2025
article
OpenAlex
Carla MC Nascimento, James D. Fluckey, Florence Lima, Brandon R. Macias et autres
us
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
M A Pulido Magaña, Carla MC Nascimento, Jaden M. Wells, Jainil Daredia et autres
Pediatric non-Hodgkin lymphoma (NHL) is a common childhood cancer. While combination chemotherapy (chemo) regimens like CHOP (cyclophosphamide, hydroxydaunorubicin, oncovin, prednisone) have significantly improved survival rates, they often induce adverse side effects. Although muscle atrophy is a well-recognized consequence of cancer therapy, the …
us
(code pays fourni par la source)
Accès ouvert
2025
preprint
OpenAlex
Jainil Daredia, Marc A Magaña, Carla MC Nascimento, Jaden M. Wells et autres
Abstract Pediatric cancer survival now exceeds 85 percent owing, in part, advances and use of combination chemotherapy treatments such as CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone). Despite its efficacy, CHOP may cause deleterious off-target effects during critical pediatric development periods such as …
us
(code pays fourni par la source)
Accès ouvert
2025
preprint
OpenAlex
Carla MC Nascimento, James D. Fluckey, Florence Lima, Brandon R. Macias et autres
Abstract Spaceflight places astronauts under both reduced mechanical loading and ionizing radiation, each of which can compromise skeletal muscle health. We investigated whether 21 days of simulated lunar gravity (one sixth G) with or without a single 0.5 Gy dose of 28 …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Michael P. Wiggs, Carla MC Nascimento, Kevin L. Shimkus, James D. Fluckey
Disuse muscle atrophy remains a major challenge in contexts such as prolonged bed rest or microgravity. Here, we investigated whether brief bouts of ambulatory reloading could attenuate skeletal muscle atrophy caused by five days of hindlimb unloading (HU) in rats. Using a …
us
(code pays fourni par la source)
2024
conference-abstract
OpenAlex
Carla MC Nascimento, M A Pulido Magaña, Jaden M. Wells, Cory M. Dungan et autres
BACKGROUND: Cisplatin is a common chemotherapy drug however, its use is associated with notably muscle wasting. Evidence suggests cisplatin-induced atrophy is caused by mitochondrial dysfunction stemming from changes to biogenesis, mitophagy, and fusion and fission, termed mitochondrial quality control. There is a …
us
(code pays fourni par la source)